Storage: Store in a cool, dry place away from direct sunlight
Slower infusion rates usually reduce or eliminate discomfort
Key Takeaways The largest study so far (semaglutide vs metformin, ~31,000 adults) found no increase in kidney stone risk despite major weight loss
Retatrutide Status: Investigational Only As of mid-2026, retatrutide remains an investigational drug
Key Takeaways GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973
Individuals taking semaglutide should be aware of the risk associated with hypoglycemia and anti-semaglutide antibody development and monitor carefully for signs of cholelithiasis (gallstones), acute kidney injury, worsening of chronic renal failure, increased heart rate and hypotension after beginning treatment